coffi

Research being done at the University of Oslo with the support of COFFI and the Oslo Fatigue Consortium MINIRICO - Mental intervention and nicotineamide riboside supplementation in Long COVID Long COVID, also referred to as post-acute sequela of COVID-19 (PASC), is present in a substantial...

Abstract Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following...

Authors Anouk Verveen, Fabiola Müller, Andrew Lloyd, Rona Moss-Morris, Torbjørn Omland, Brenda Penninx, Ruud P.H. Raijmakers, Marike van der Schaaf, Carolina X. Sandler, Knut Stavem, Simon Wessely, Vegard B.B.Wyller, Pythia Nieuwkerk, Hans Knoop 1. Background Now that the COVID-19 pandemic...

Abstract Fatigue is a dominant feature of both acute and convalescent COVID-19 (sometimes termed ‘long-COVID’), with up to 46% of patients reporting fatigue lasting weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic...

The international collaborative on fatigue following infection (COFFI), 2018, Katz et al. Ben Z Katz,Simon M Collin,Gabrielle Murphy,Rona Moss-Morris,Vegard Bruun Wyller,Knut-Arne Wensaas,Jeannine L.A. Hautvast,Chantal P Bleeker-Rovers,Ute Vollmer-Conna,Dedra Buchwald,Renée Taylor,Paul...